Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Koji Shinkai
Observed names:
K. Shinkai,
KOJI SHINKAI,
新開浩二
Institution:
University of Occupational and Environmental Health Japan
Observed institutions:
University of Occupational and Environmental Health Japan,
Japanese Society of Clinical Neuropsychopharmacology,
Hospital of the University of Occupational and Environmental Health
OpenAlex ID:
A5085646540
High-Frequency Repetitive Transcranial Magnetic Stimulation Improves Refractory Depression by Influencing Catecholamine and Brain-Derived Neurotrophic Factors
2006
·
T. Yukimasa
, R. Yoshimura
, et al.
·
Pharmacopsychiatry
·
158
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6
2005
·
Shingo Kakihara
, Reiji Yoshimura
, et al.
·
International Clinical Psychopharmacology
·
95
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients
2007
·
Reiji Yoshimura
, Hikaru Hori
, et al.
·
Progress in Neuro-Psychopharmacology and Biological Psychiatry
·
58
Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia
2003
·
Reiji Yoshimura
, Nobuhisa Ueda
, et al.
·
International Clinical Psychopharmacology
·
52
Associations Between Baseline Plasma MHPG (3-methoxy-4-hydroxyphenylglycol) Levels and Clinical Responses With Respect to Milnacipran Versus Paroxetine Treatment
2004
·
Koji Shinkai
, Reiji Yoshimura
, et al.
·
Journal of Clinical Psychopharmacology
·
43
Plasma Levels of Catecholamine Metabolites Predict the Response to Sulpiride or Fluvoxamine in Major Depression
2002
·
N. Ueda
, R. Yoshimura
, et al.
·
Pharmacopsychiatry
·
39
Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review
2004
·
Reiji Yoshimura
, Jun Nakamura
, et al.
·
Progress in Neuro-Psychopharmacology and Biological Psychiatry
·
37
Risperidone in the treatment of psychotic depression
2006
·
Makiko Goto
, Reiji Yoshimura
, et al.
·
Progress in Neuro-Psychopharmacology and Biological Psychiatry
·
36
Successful treatment for obsessive‐compulsive disorder with addition of low‐dose risperidone to fluvoxamine: Implications for plasma levels of catecholamine metabolites and serum brain‐derived neurotrophic factor levels
2006
·
REIJI YOSHIMURA
, SACHIKO KANEKO
, et al.
·
Psychiatry and Clinical Neurosciences
·
29
PDF
Higher Plasma 5-Hydroxyindoleacetic Acid Levels Are Associated with SSRI-Induced Nausea
2003
·
Nobuhisa Ueda
, Reiji Yoshimura
, et al.
·
Neuropsychobiology
·
29
Grapefruit Juice-fluvoxamine Interaction
2003
·
Hiroko Hori
, Reiji Yoshimura
, et al.
·
Journal of Clinical Psychopharmacology
·
24
Valproic Acid improves Psychotic Agitation without Influencing Plasma Risperidone Levels in Schizophrenic Patients
2007
·
R. Yoshimura
, K. Shinkai
, et al.
·
Pharmacopsychiatry
·
23
An open study of risperidone liquid in the acute phase of schizophrenia
2005
·
Reiji Yoshimura
, Jun Nakamura
, et al.
·
Human Psychopharmacology Clinical and Experimental
·
21
Selective blockade of nicotinic acetylcholine receptors by pimobendan, a drug for the treatment of heart failure: reduction of catecholamine secretion and synthesis in adrenal medullary cells
2005
·
Yumiko Toyohira
, Tatsuhiko Kubo
, et al.
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
12
Effect of clonazepam treatment on antipsychotic drug‐induced Meige syndrome and changes in plasma levels of GABA, HVA, and MHPG during treatment
2001
·
Reiji Yoshimura
, Shingo Kakihara
, et al.
·
Psychiatry and Clinical Neurosciences
·
11
Characteristics of fluvoxamine-induced nausea
2001
·
Nobuhisa Ueda
, Reiji Yoshimura
, et al.
·
Psychiatry Research
·
10
A Case of Myasthenia Gravis Preceded by Major Depression
2001
·
Koji Shinkai
, Osamu Ohmori
, et al.
·
Journal of Neuropsychiatry
·
10
Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran
2007
·
Koji Shinkai
, Yumiko Toyohira
, et al.
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
7
Effects of olanzapine on plasma levels of monoamine metabolites and brain-derived neurotrophic factor in schizophrenic patients
2006
·
Hikaru Hori
, Reiji Yoshimura
, et al.
·
International Clinical Psychopharmacology
·
5
Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cells
2005
·
Reiji Yoshimura
, Koji Shinkai
, et al.
·
Human Psychopharmacology Clinical and Experimental
·
5
Two Cases of Bipolar Disorder Successfully Stabilized for Five Years with a Low Dose of Risperidone and Lithium
2006
·
R. Yoshimura
, N. Ueda
, et al.
·
Pharmacopsychiatry
·
4
Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells
2005
·
Koji Shinkai
, Reiji Yoshimura
, et al.
·
Biochemical Pharmacology
·
4
Effects of repeated milnacipran administration on brain serotonergic and noradrenergic functions in healthy volunteers
2006
·
Atsushi Soya
, Takeshi Terao
, et al.
·
Psychopharmacology
·
3
Little Effects of Low Dosage of Levomepromazine on Plasma Risperidone Levels
2005
·
R. Yoshimura
, K. Shinkai
, et al.
·
Pharmacopsychiatry
·
3
Association between plasma 3-methoxy-4-hydroxy-phenylethylene glycol levels and serum brain-derived neurotrophic factor levels in healthy workers
2006
·
Masae Mitoma
, Reiji Yoshimra
, et al.
·
International Clinical Psychopharmacology
Show more works
View as search
Works count:
43
Citation count:
718
H-index:
13
I10-index:
17
Year
Topic
Type